Login/Register

News

PharmaEssentia Expands to Vietnam with New Drug Launch

PharmaEssentia announced yesterday that it has applied for market approval in Vietnam for its new drug, BESREMi (Ropeginterferon alfa-2b, also known as Ropeg or P1101), for the treatment of Polycythemia Vera (PV), marking its expansion into the Southeast Asian market.

Read more
Apr 02, 2025
Apr 01, 2025
Apr 01, 2025
Apr 01, 2025
Mar 31, 2025
Mar 31, 2025
Mar 31, 2025
Mar 30, 2025
Mar 30, 2025